Loading…
Sunshine Biopharma Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in SBFM.
▼ -100.0% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $12.30 | $30.00 | $5,440.00 | $12,800.00 | |
| P/S | 0.3x | 0.2x | 0.2x | 0.3x | 3.3x |
| P/B | 0.3x | 0.3x | 0.3x | 0.4x | 0.7x |
| EPS | -$14.40 | -$73.20 | -$3,513.60 | -$23,688.61 | |
| Profit margin | -17.58% | -16.46% |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| SILOSilo Pharma, Inc. | $2.54 | — | 0.5x | — | -91.23% | $4.45M |
| XAIRBeyond Air, Inc. | $4.48 | 0.0x | 0.4x | — | -519.51% | $4.41M |
| VVOSVivos Therapeutics, Inc. | $0.22 | — | — | — | -8585.26% | $4.52M |
| ELABPMGC Holdings Inc. | $5.31 |
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Company description provided by Yahoo Finance.
| -14.72% |
| -18.70% |
| -615.44% |
| ROE | -23.89% | -25.94% | -21.85% | -21.25% | -123.66% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 0.2x |
| — |
| -105.22% |
| $4.3M |
| APVOAptevo Therapeutics Inc. | $2.37 | 0.0x | 0.6x | — | -420.34% | $4.26M |
| XRTXXORTX Therapeutics Inc. | $2.34 | — | 1.6x | — | -99.24% | $4.25M |